Literature DB >> 26110137

Pulmonary Tuberculosis in a Patient with Cystic Fibrosis.

Naveen Patil1, Asween Marco2, Maria Theresa Montales3, Nutan Bhaskar3, Penchala Mittadodla3, Leonard N Mukasa1.   

Abstract

CONTEXT: Mycobacterium tuberculosis (MTB) infection is rarely seen in cystic fibrosis (CF) patients. CASE REPORT: We report a 24-year-old CF patient with fever, cough, hemoptysis, and weight loss of 1week duration prior to admission. Past sputum cultures grew methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa. The patient was treated with broad spectrum antibiotics based on previous culture data, but failed to improve. Chest radiograph and computed tomography (CT) chest revealed chronic collapse of the anterior subsegment of right upper lobe and multiple bilateral cavitary lesions which were worse compared to prior films. MTB was suspected and was confirmed by positive acid-fast bacilli (AFB) smears and cultures. After receiving first-line antituberculous drugs, the patient's condition markedly improved.
CONCLUSION: MTB is an infrequent finding, but considered a potential pathogen in CF patients, and may lead to serious pulmonary complications if there is a delay in diagnosis and treatment.

Entities:  

Keywords:  AFB; Cystic fibrosis; GeneXpert MTB/RIF assay; Genotyping; MTB

Year:  2015        PMID: 26110137      PMCID: PMC4462821          DOI: 10.4103/1947-2714.157494

Source DB:  PubMed          Journal:  N Am J Med Sci        ISSN: 1947-2714


  16 in total

1.  Cystic fibrosis complicated by multiresistant tuberculosis.

Authors:  Irina K Asherova; Jean Feigelson; Ludmila A Vasilyeva; Valery J Gabitov
Journal:  Acta Paediatr       Date:  2006-11       Impact factor: 2.299

Review 2.  Treatment of tuberculosis: present status and future prospects.

Authors:  Philip Onyebujoh; Alimuddin Zumla; Isabella Ribeiro; Roxana Rustomjee; Peter Mwaba; Melba Gomes; John M Grange
Journal:  Bull World Health Organ       Date:  2005-11-10       Impact factor: 9.408

3.  [Tuberculous pneumopathy in the course of cystic fibrosis].

Authors:  J Feigelson; B Delaisi; Y Pecau; A Kerzoncuf; C Anagnostopoulos; G Tournier
Journal:  Arch Pediatr       Date:  1997-12       Impact factor: 1.180

4.  TB or not TB; don't miss the obvious.

Authors:  Naveen Patil; Asween Marco; Hamida Saba; Rohan Samant; Leonard Mukasa
Journal:  J Ark Med Soc       Date:  2014-11

5.  Hypothesis: a selective advantage for cystic fibrosis heterozygotes.

Authors:  R S Meindl
Journal:  Am J Phys Anthropol       Date:  1987-09       Impact factor: 2.868

6.  Mediastinal tuberculosis in an adult patient with cystic fibrosis.

Authors:  Philippe C Morand; Pierre-Régis Burgel; Agnès Carlotti; Nadine Desmazes-Dufeu; David Farhi; Clémence Martin; Reem Kanaan; Luigi Mangialavori; Estelle Palangié; Daniel Dusser; Claire Poyart; Dominique Hubert
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

7.  [Nontuberculous mycobacterial infection in patients with cystic fibrosis: a multicenter prevalence study].

Authors:  Rosa M Girón; Luis Máiz; Isabel Barrio; M Teresa Martínez; Antonio Salcedo; Concepción Prados
Journal:  Arch Bronconeumol       Date:  2008-12       Impact factor: 4.872

8.  Initial experience with GeneXpert MTB/RIF assay in the Arkansas Tuberculosis Control Program.

Authors:  Naveen Patil; Hamida Saba; Asween Marco; Rohan Samant; Leonard Mukasa
Journal:  Australas Med J       Date:  2014-05-31

Review 9.  Does deficiency of arylsulfatase B have a role in cystic fibrosis?

Authors:  Joanne K Tobacman
Journal:  Chest       Date:  2003-06       Impact factor: 9.410

10.  The road to tuberculosis (Mycobacterium tuberculosis) elimination in Arkansas; a re-examination of risk groups.

Authors:  Anna Berzkalns; Joseph Bates; Wen Ye; Leonard Mukasa; Anne Marie France; Naveen Patil; Zhenhua Yang
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

View more
  6 in total

1.  Cystic fibrosis carriership and tuberculosis: hints toward an evolutionary selective advantage based on data from the Brazilian territory.

Authors:  Lander Bosch; Barbara Bosch; Kris De Boeck; Tim Nawrot; Isabelle Meyts; Dominique Vanneste; Cleonice Alexandre Le Bourlegat; Julio Croda; Luiz Vicente Ribeiro Ferreira da Silva Filho
Journal:  BMC Infect Dis       Date:  2017-05-12       Impact factor: 3.090

Review 2.  The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases.

Authors:  Susan L Baldwin; Sasha E Larsen; Diane Ordway; Gail Cassell; Rhea N Coler
Journal:  PLoS Negl Trop Dis       Date:  2019-02-14

3.  Aetiological agents for pulmonary exacerbations in children with cystic fibrosis: An observational study from a tertiary care centre in northern India.

Authors:  Balaji Arvind; Guruprasad R Medigeshi; Arti Kapil; Immaculata Xess; Urvashi Singh; Rakesh Lodha; Sushil Kumar Kabra
Journal:  Indian J Med Res       Date:  2020-01       Impact factor: 2.375

4.  Tuberculosis reinfection in a pregnant cystic fibrosis patient.

Authors:  Asween Marco; Maria Theresa Montales; Penchala Mittadodla; Leonard Mukasa; Nutan Bhaskar; Joseph Bates; Naveen Patil
Journal:  Respir Med Case Rep       Date:  2015-04-23

Review 5.  HIV-Associated TB Syndemic: A Growing Clinical Challenge Worldwide.

Authors:  Maria Theresa Montales; Arun Chaudhury; Alexandria Beebe; Sowmya Patil; Naveen Patil
Journal:  Front Public Health       Date:  2015-12-23

6.  Mycobacterium tuberculosis infection in a HIV-positive patient.

Authors:  Maria Theresa Montales; Alexandria Beebe; Arun Chaudhury; Naveen Patil
Journal:  Respir Med Case Rep       Date:  2015-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.